Macy's
M NYSE Broadline Retail Financials FY2016βFY2025
Macy's revenue fell 1.7% to $22.6 billion in fiscal 2025. Its operating margin was 4.5%, up from 4.0% a year earlier. Free cash flow was $1.1 billion, up 39.1%. It paid out $447 million in dividends and buybacks, 42% of free cash flow. The diluted share count fell 1.8%.
What Macy's does
No business description yet.
- Legal name
- Macy's, Inc.
- Fiscal year ends
- January 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-021721
0000794367
Revenue and margins
Macy's had $22.6B of revenue in fiscal 2025, down 1.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 1.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1B in fiscal 2025, 4.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Macy's returned $447M to shareholders in fiscal 2025, 42% of free cash flow. The diluted share count fell 1.8%.
Value Macy's yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.2B and divides by 276.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 8.8x Β· peers 30.0x Β· sector 17.9x.
Balance sheet
Cash, debt and the ratios that show how comfortably Macy's can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.7B | $862M | $1.0B | $1.3B | $1.2B |
| Debt incl. finance leases | $3.3B | $3.0B | $3.0B | $2.8B | $2.4B |
| Net debt / EBITDA | 0.5x | 0.8x | 1.7x | 0.8x | 0.6x |
| Debt / equity | 0.9x | 0.7x | 0.8x | 0.6x | 0.5x |
| Interest coverage | 9.2x | 9.7x | 1.8x | 5.8x | 7.4x |
| Current ratio | 1.3x | 1.2x | 1.3x | 1.4x | 1.5x |
| Quick ratio | 0.4x | 0.3x | 0.4x | 0.4x | 0.5x |
| Total assets | $17.6B | $16.9B | $16.2B | $16.4B | $16.2B |
| Total liabilities | $14.0B | $12.8B | $12.2B | $11.9B | $11.4B |
| Shareholders' equity | $3.6B | $4.1B | $4.0B | $4.6B | $4.9B |
| Net debt (β = net cash) | $1.6B | $2.2B | $2.0B | $1.5B | $1.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$3.0M
6 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Paul GriscomSVP and Controller | Sold | 10,077 | $25.63 | $0.3M | Form 4 |
| Jun 24, 2026 | Thomas Edwards Jr.EVP, COO & CFO | Sold | 16,419 | $24.89 | $0.4M | Form 4 |
| Apr 6, 2026 | Antony SpringChairman & CEO, Director | Sold | 50,044 | $17.92 | $0.9M | Form 4 |
| Apr 6, 2026 | Danielle L. KirganEVP, Chief HR Officer | Sold | 10,010 | $17.92 | $0.2M | Form 4 |
| Apr 6, 2026 | Olivier BronCEO, Bloomingdale's | Sold | 7,228 | $17.92 | $0.1M | Form 4 |
| Apr 6, 2026 | Paul GriscomSVP and Controller | Sold | 745 | $17.92 | $0.0M | Form 4 |
| Apr 6, 2026 | Tracy M PrestonEVP, CLO & Corporate Secretary | Sold | 5,271 | $17.92 | $0.1M | Form 4 |
| Apr 1, 2026 | Antony SpringChairman & CEO, Director | Sold | 14,606 | $18.08 | $0.3M | Form 4 |
| Apr 1, 2026 | Danielle L. KirganEVP, Chief HR Officer | Sold | 6,573 | $18.08 | $0.1M | Form 4 |
| Apr 1, 2026 | Paul GriscomSVP and Controller | Sold | 490 | $18.08 | $0.0M | Form 4 |
| Mar 30, 2026 | Antony SpringChairman & CEO, Director | Sold | 27,451 | $17.73 | $0.5M | Form 4 |
| Mar 30, 2026 | Danielle L. KirganEVP, Chief HR Officer | Sold | 5,161 | $17.73 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 7 / 9 | 8 / 9 |
| Accruals ratio | β7.6% | β4.3% | β4.8% |
| Altman Z'' | 2.32 | 2.85 | 3.15 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Macy's M | $6.6B | β1.7% | 4.6% | 4.7% | 12.9% | 8.8x | 8 | |
| Sea Limited SE | $47.6B | 36.4% | 8.7% | 19.7% | β | β | 8 | Compare β |
| MercadoLibre MELI | $91.8B | 39.1% | 11.1% | 37.3% | 35.0% | 49.2x | 4 | Compare β |
| Kohl's KSS | $2.9B | β4.3% | 4.0% | 6.5% | 7.2% | 10.7x | 7 | Compare β |
| Coupang CPNG | $25.0B | 14.1% | 1.4% | 1.5% | β | β | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $25.9B | $24.9B | $25.0B | $24.6B | $17.3B | $25.4B | $25.4B | $23.9B | $23.0B | $22.6B |
| Gross profit | $10.2B | $9.7B | $9.8B | $9.4B | $5.1B | $10.4B | $10.1B | $9.6B | $9.3B | $9.1B |
| Operating income | $1.4B | $1.9B | $1.7B | $970M | β$4.5B | $2.4B | $1.7B | $301M | $909M | $1.0B |
| Interest expense | $367M | $321M | $261M | $205M | $284M | $256M | $175M | $170M | $158M | $139M |
| Pretax income | $965M | $1.5B | $1.4B | $728M | β$4.8B | $1.9B | $1.5B | $43.0M | $763M | $849M |
| Income tax | $346M | β$39.0M | $322M | $164M | β$846M | $436M | $331M | β$2.0M | $181M | $207M |
| Net income | $627M | $1.6B | $1.1B | $564M | β$3.9B | $1.4B | $1.1B | $45.0M | $582M | $642M |
| Diluted EPS | $2.02 | $5.10 | $3.56 | $1.81 | β$12.68 | $4.55 | $4.08 | $0.16 | $2.07 | $2.32 |
| Diluted shares | 0.31B | 0.31B | 0.31B | 0.31B | 0.31B | 0.31B | 0.28B | 0.28B | 0.28B | 0.28B |
| Cash flow | ||||||||||
| Cash from operations | $1.8B | $2.0B | $1.7B | $1.6B | $649M | $2.7B | $1.6B | $1.3B | $1.3B | $1.4B |
| Capital expenditure | $596M | $487M | $657M | $902M | $338M | $354M | $888M | $631M | $518M | $373M |
| Free cash flow | $1.2B | $1.5B | $1.1B | $706M | $311M | $2.4B | $727M | $674M | $760M | $1.1B |
| Depreciation and amortization | $1.1B | $991M | $962M | $981M | $959M | $874M | $857M | $897M | $881M | $894M |
| Stock-based compensation | $61.0M | $58.0M | $63.0M | $38.0M | $31.0M | $55.0M | $54.0M | $47.0M | $58.0M | $59.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $316M | $1.0M | $0.0M | $1.0M | $1.0M | $500M | $601M | $38.0M | $1.0M | $250M |
| Dividends paid | $459M | $461M | $463M | $466M | $117M | $90.0M | $173M | $181M | $192M | $197M |
| Dividends and buybacks | $775M | $462M | $463M | $467M | $118M | $590M | $774M | $219M | $193M | $447M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.3B | $1.5B | $1.2B | $685M | $1.7B | $1.7B | $862M | $1.0B | $1.3B | $1.2B |
| Total debt | $6.4B | $5.8B | $4.4B | $4.2B | $4.8B | $3.3B | $3.0B | $3.0B | $2.8B | $2.4B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $23.0M | $21.0M | $19.0M | $17.0M | $14.0M | $15.0M | $13.0M |
| Current assets | $7.6B | $7.6B | $7.4B | $6.8B | $6.2B | $6.8B | $5.9B | $6.1B | $6.5B | $6.7B |
| Current liabilities | $5.6B | $5.2B | $5.2B | $5.8B | $5.4B | $5.4B | $4.9B | $4.5B | $4.5B | $4.5B |
| Inventory | $5.4B | $5.2B | $5.3B | $5.2B | $3.8B | $4.4B | $4.3B | $4.4B | $4.5B | $4.4B |
| Property and equipment, net | $7.0B | $6.7B | $6.6B | $6.6B | $5.9B | $5.7B | $5.9B | $5.3B | $5.1B | $4.7B |
| Total assets | $19.9B | $19.6B | $19.2B | $21.2B | $17.7B | $17.6B | $16.9B | $16.2B | $16.4B | $16.2B |
| Total liabilities | $15.5B | $13.9B | $12.8B | $14.8B | $15.2B | $14.0B | $12.8B | $12.2B | $11.9B | $11.4B |
| Shareholders' equity | $4.3B | $5.7B | $6.4B | $6.4B | $2.6B | $3.6B | $4.1B | $4.0B | $4.6B | $4.9B |
| Margins | ||||||||||
| Gross margin | 39.2% | 38.8% | 39.1% | 38.2% | 29.2% | 41.1% | 39.7% | 40.4% | 40.3% | 40.3% |
| Operating margin | 5.3% | 7.5% | 7.0% | 4.0% | β25.8% | 9.3% | 6.6% | 1.3% | 4.0% | 4.6% |
| EBITDA margin | 9.4% | 11.5% | 10.8% | 7.9% | β20.3% | 12.7% | 10.0% | 5.0% | 7.8% | 8.5% |
| Net margin | 2.4% | 6.3% | 4.4% | 2.3% | β22.7% | 5.6% | 4.5% | 0.2% | 2.5% | 2.8% |
| FCF margin | 4.7% | 6.0% | 4.3% | 2.9% | 1.8% | 9.3% | 2.9% | 2.8% | 3.3% | 4.7% |
| Returns | ||||||||||
| Return on capital | 9.1% | 19.1% | 13.6% | 7.7% | β45.3% | 33.1% | 23.0% | 4.9% | 11.5% | 12.9% |
| Return on capital employed | 9.4% | 13.0% | 12.3% | 6.6% | β32.2% | 19.2% | 14.0% | 2.5% | 7.7% | 8.7% |
| Return on equity | 14.6% | 31.1% | 18.2% | 8.8% | β88.3% | 46.3% | 29.8% | 1.1% | 13.6% | 13.6% |
| Return on assets | 3.1% | 7.9% | 5.7% | 2.8% | β20.3% | 8.1% | 6.7% | 0.3% | 3.6% | 3.9% |
| Growth | ||||||||||
| Revenue growth | β4.3% | β3.7% | 0.1% | β1.7% | β29.4% | 46.4% | 0.2% | β6.2% | β3.6% | β1.7% |
| Net income growth | β41.5% | 149.8% | β29.3% | β49.1% | β799.3% | β | β19.9% | β96.1% | 1,193.3% | 10.3% |
| EPS growth | β37.3% | 152.5% | β30.2% | β49.2% | β800.6% | β | β10.3% | β96.1% | 1,193.8% | 12.1% |
| FCF growth | β0.2% | 23.6% | β27.6% | β34.5% | β56.0% | 658.2% | β69.2% | β7.3% | 12.8% | 39.1% |
| Share count change | β6.7% | β1.3% | 1.5% | 0.0% | β0.1% | 0.9% | β10.5% | β1.0% | 1.2% | β1.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.1x | 1.5x | 1.2x | 1.8x | β | 0.5x | 0.8x | 1.7x | 0.8x | 0.6x |
| Debt / equity | 1.5x | 1.0x | 0.7x | 0.7x | 1.9x | 0.9x | 0.7x | 0.8x | 0.6x | 0.5x |
| Interest coverage | 3.7x | 5.8x | 6.7x | 4.7x | β15.8x | 9.2x | 9.7x | 1.8x | 5.8x | 7.4x |
| Current ratio | 1.4x | 1.5x | 1.4x | 1.2x | 1.2x | 1.3x | 1.2x | 1.3x | 1.4x | 1.5x |
| Quick ratio | 0.4x | 0.5x | 0.4x | 0.3x | 0.5x | 0.4x | 0.3x | 0.4x | 0.4x | 0.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.3% | 2.0% | 2.6% | 3.7% | 2.0% | 1.4% | 3.5% | 2.6% | 2.3% | 1.7% |
| Stock comp / revenue | 0.2% | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% |
| Payouts / FCF | 64.3% | 31.0% | 43.0% | 66.2% | 37.9% | 25.0% | 106.5% | 32.5% | 25.4% | 42.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 7.0 | 6.0 | 6.0 | 3.0 | 8.0 | 6.0 | 6.0 | 7.0 | 8.0 |
| Altman Z'' | 2.4 | 3.1 | 3.3 | 2.3 | β0.5 | 2.7 | 2.6 | 2.3 | 2.9 | 3.2 |
| Accruals ratio | β5.8% | β2.1% | β3.2% | β5.2% | β23.6% | β7.3% | β2.7% | β7.6% | β4.3% | β4.8% |
Source: SEC EDGAR XBRL filings (CIK 0000794367). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.